Is Baxter International Inc. overvalued?

Baxter International Inc. (BAX) looks overvalued — trading about 12% above its fair value.

Overvalued

Price

$25.81

Fair value

$22.63

Current P/E

12.4

Normal P/E

10.9

Market cap

$13.35B

Dividend yield

0.2%

Return on equity

-11.6%

Sector

Healthcare

Fair value compares BAX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks